Home Tags Hatch-Waxman Act

Tag: Hatch-Waxman Act

Pharmaceutical Antitrust Complexity

This article is part of a Chronicle. See more from this Chronicle Michael Carrier, Nov 24, 2014 The pharmaceutical industry is unique in its complexity. Markets...

Generic Drugmakers Will Challenge Patents Even When They Have a 97%...

Jonathan Gleklen, Kelly Smith, Sep 13, 2012 A striking aspect of the Third Circuit's decision on Hatch-Waxman patent settlements in the K-Dur litigation is the panel's...

Cervantes Sequel: The FTC’s Quest to End Pay-for-Delay Pharma Settlements

Anne Layne-Farrar, Jun 27, 2012 We are drawing close to the thirtieth anniversary of the Drug Price Competition and Patent Term Restoration Act, better known...

Reverse Payment Settlements: Presumptively Bad or Usually Acceptable?

Kyle Musgrove, Richard Ripley, Jun 27, 2012 In April 2012, the Federal Trade Commission ("FTC") suffered yet another rebuke of what FTC Chair Jon Leibowitz...

Federal Trade Commission Rejected in “Reverse Payment” Suit

Kevin Noonan, Jun 27, 2012 The Federal Trade Commission in recent years has identified a practice it considers to be a threat to consumers regarding...

News

Enable Notifications    OK No thanks